SynthesisRespiratory research2016

Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis.

Jian Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.